INVO Fertility (IVF) Common Equity (2010 - 2025)

INVO Fertility has disclosed Common Equity across 16 years of filings, most recently posting $5.8 million for Q3 2025.

• Quarterly Common Equity rose 25184.59% year-over-year to $5.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.8 million (up 25184.59% YoY) and the FY2024 annual result came in at $12.7 million, up 1327.77% from the prior year.
• Common Equity rose to $5.8 million in Q3 2025, from $2.6 million in the prior quarter.
• Across five years, Common Equity topped out at $12.7 million in Q4 2024 and bottomed at -$1.7 million in Q2 2023.
• The 5-year median for Common Equity is $2.4 million (2021), against an average of $2.9 million.
• Year-over-year, Common Equity tumbled 150.81% in 2023 and surged 32744.56% in 2025.
• INVO Fertility's Common Equity stood at $7.3 million in 2021, then plunged by 113.37% to -$977612.0 in 2022, then surged by 191.33% to $892825.0 in 2023, then jumped by 1327.77% to $12.7 million in 2024, then sank by 54.12% to $5.8 million in 2025.
• According to Business Quant data, Common Equity over the past three periods registered $5.8 million, $2.6 million, and $3.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.